{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:52:45Z","timestamp":1775868765442,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bbih.2021.100217","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T12:29:52Z","timestamp":1612960192000},"page":"100217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy"],"prefix":"10.1016","volume":"13","author":[{"given":"Michael","family":"Repajic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Lei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prissilla","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbih.2021.100217_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/coa.13293","article-title":"Recurrent Bell\u2019s palsy","volume":"44","author":"Dong","year":"2019","journal-title":"Clin. Otolaryngol."},{"issue":"6494","key":"10.1016\/j.bbih.2021.100217_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbih.2021.100217_bib3","unstructured":"Moderna COVID-19 vaccine vaccines and related biological products advisory committee meeting (VRBPAC) Briefing Document December 17, 2020."},{"issue":"9","key":"10.1016\/j.bbih.2021.100217_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbih.2021.100217_bib5","unstructured":"Pfizer-BioNTech COVID-19 vaccine vaccines and related biological products advisory committee meeting (VRBPAC) Briefing Document December 10, 2020."},{"issue":"12","key":"10.1016\/j.bbih.2021.100217_bib6","first-page":"786","article-title":"Vaccine adverse events: separating myth from reality","volume":"95","author":"Spencer","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbih.2021.100217_bib7","unstructured":"The Center for Disease Control and Prevention: Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States January vol. 6, 2021."},{"issue":"8","key":"10.1016\/j.bbih.2021.100217_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A\u00a0potential signal of Bell\u2019s palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266635462100020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266635462100020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:08:12Z","timestamp":1775866092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266635462100020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":8,"alternative-id":["S266635462100020X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2021.100217","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2021.100217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100217"}}